These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 17852836)

  • 1. Butyrylcholinesterase K variants increase the risk of coronary artery disease in the population of western Iran.
    Vaisi-Raygani A; Rahimi Z; Entezami H; Kharrazi H; Bahrhemand F; Tavilani H; Rezaei M; Kiani A; Nomanpour B; Pourmotabbed T
    Scand J Clin Lab Invest; 2008; 68(2):123-9. PubMed ID: 17852836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Butyrylcholinesterase K variant and the APOE-epsilon 4 allele work in synergy to increase the risk of coronary artery disease especially in diabetic patients.
    Vaisi-Raygani A; Rahimi Z; Tavilani H; Pourmotabbed T
    Mol Biol Rep; 2010 Apr; 37(4):2083-91. PubMed ID: 19685167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The presence of apolipoprotein epsilon4 and epsilon2 alleles augments the risk of coronary artery disease in type 2 diabetic patients.
    Vaisi-Raygani A; Rahimi Z; Nomani H; Tavilani H; Pourmotabbed T
    Clin Biochem; 2007 Oct; 40(15):1150-6. PubMed ID: 17689519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variation of the butyrylcholinesterase (BChE) and acetylcholinesterase (AChE) genes in coronary artery disease.
    Scacchi R; Ruggeri M; Corbo RM
    Clin Chim Acta; 2011 Jul; 412(15-16):1341-4. PubMed ID: 21473860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factor V G1691A, prothrombin G20210A and methylenetetrahydrofolate reductase polymorphism C677T are not associated with coronary artery disease and type 2 diabetes mellitus in western Iran.
    Rahimi Z; Nomani H; Mozafari H; Vaisi-Raygani A; Madani H; Malek-Khosravi S; Parsian A
    Blood Coagul Fibrinolysis; 2009 Jun; 20(4):252-6. PubMed ID: 19349859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of association between butyrylcholinesterase K variant and apolipoprotein E genotypes in Alzheimer's disease.
    Raygani AV; Zahrai M; Soltanzadeh A; Doosti M; Javadi E; Pourmotabbed T
    Neurosci Lett; 2004 Nov; 371(2-3):142-6. PubMed ID: 15519745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved prediction of early-onset coronary artery disease using APOE epsilon4, BChE-K, PPARgamma2 Pro12 and ENOS T-786C in a polygenic model.
    Nassar BA; Rockwood K; Kirkland SA; Ransom TP; Darvesh S; MacPherson K; Johnstone DE; O'Neill BJ; Bata IR; Andreou P; Jeffery JS; Cox JL; Title LM
    Clin Biochem; 2006 Feb; 39(2):109-14. PubMed ID: 16298355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between apolipoprotein E polymorphism and coronary artery disease in the Kermanshah population in Iran.
    Kharrazi H; Vaisi Raygani A; Sabokroh AR; Pourmotabbed T
    Clin Biochem; 2006 Jun; 39(6):613-6. PubMed ID: 16545358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of endothelial nitric oxide synthase gene variant (G894T) with coronary artery disease in Western Iran.
    Rahimi Z; Nourozi-Rad R
    Angiology; 2012 Feb; 63(2):131-7. PubMed ID: 21602253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Butyrylcholinesterase activity and risk factors for coronary artery disease.
    Alcântara VM; Chautard-Freire-Maia EA; Scartezini M; Cerci MS; Braun-Prado K; Picheth G
    Scand J Clin Lab Invest; 2002; 62(5):399-404. PubMed ID: 12387587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of variants of the -116 site of the butyrylcholinesterase BCHE gene to enzyme activity and body mass index.
    Furtado-Alle L; Andrade FA; Nunes K; Mikami LR; Souza RL; Chautard-Freire-Maia EA
    Chem Biol Interact; 2008 Sep; 175(1-3):115-8. PubMed ID: 18550040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation between butyrylcholinesterase K variant, paraoxonase 1 (PON1) Q and R and apolipoprotein E epsilon 4 genes in early-onset coronary artery disease.
    Nassar BA; Darvesh S; Bevin LD; Rockwood K; Kirkland SA; O'Neill BJ; Bata IR; Johnstone DE; Title LM
    Clin Biochem; 2002 May; 35(3):205-9. PubMed ID: 12074828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.
    Kowalski M
    J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of butyrylcholinesterase (BChE) phenotypes to predict the risk of prolonged apnea in persons receiving succinylcholine in the healthy population of western Iran.
    Vaisi-Raygani A; Rahimi Z; Kharazi H; Tavilani H; Aminiani M; Kiani A; Vaisi-Raygani A; Pourmotabbed T
    Clin Biochem; 2007 Jun; 40(9-10):629-33. PubMed ID: 17350607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association analysis between K and -116A variants of butyrylcholinesterase and Alzheimer's disease in a Brazilian population.
    Simão-Silva DP; Bertolucci PH; de Labio RW; Payão SL; Furtado-Alle L; Souza RL
    Chem Biol Interact; 2013 Mar; 203(1):358-60. PubMed ID: 23022600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response to succinylcholine in patients carrying the K-variant of the butyrylcholinesterase gene.
    Bretlau C; Sørensen MK; Vedersoe AL; Rasmussen LS; Gätke MR
    Anesth Analg; 2013 Mar; 116(3):596-601. PubMed ID: 23400986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein ε4 modulates phenotype of butyrylcholinesterase in CSF of patients with Alzheimer's disease.
    Darreh-Shori T; Siawesh M; Mousavi M; Andreasen N; Nordberg A
    J Alzheimers Dis; 2012; 28(2):443-58. PubMed ID: 22012848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency and enzyme activity of the butyrylcholinesterase K-variant in a Turkish population.
    Babaoglu MO; Ocal T; Bayar B; Kayaalp SO; Bozkurt A
    Eur J Clin Pharmacol; 2004 Feb; 59(12):875-7. PubMed ID: 14735258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homozygosity for the K variant of BCHE gene increases the risk for development of neurofibrillary pathology but not amyloid deposits at young ages.
    Ghebremedhin E; Thal DR; Schultz C; Braak H; Deller T
    Acta Neuropathol; 2007 Oct; 114(4):359-63. PubMed ID: 17701416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Association of C1019T polymorphism in the connexin 37 gene and coronary artery disease in Chinese Han population].
    Han YL; Xi SY; Zhang XL; Yan CH; Yang Y; Kang J
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(2):100-4. PubMed ID: 17418016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.